These findings suggest that Metrnl exerts a protective effect on DKD kidneys, potentially by inhibiting the expression of TGF-β1/Smads signaling pathway, thereby reducing the production of fibrotic molecules such as α-SMA. Here, ACTA1 is linked to diabetic kidney disease.